INEXION
The Longevity Data Registry
Longevity Medicine · Multi-Source Registry · Partner-Led

The infrastructure
layer for longevity
medicine.

Building the longitudinal patient dataset every incumbent claims-based platform is structurally blind to. Through partnerships with longevity clinics, telehealth platforms, and medical societies.

For Physicians For Life Sciences For Investors
$128B+
TAM — U.S. longevity & regenerative care
50K+
Patient-years · 2027 Series A target
5
Public datasets integrated
The Problem

Longevity medicine is generating extraordinary data.
Almost none of it is being captured.

Longevity care is delivered through thousands of independent cash-pay practices — outside hospital systems, outside insurance networks. This patient population generates zero claims data. IQVIA, Komodo, Symphony, and every legacy health-data platform are structurally blind to it. The most valuable cohort in healthcare is invisible to the systems built to study it. INEXION is the entity capturing it.

01
The Data Registry
A multi-source longitudinal health registry — de-identified, structured, outcomes-linked. The clinical-grade longevity dataset that has never existed in any licensable form.
02
Three Data Layers
Public-data spine (NHANES, BRFSS, HRS, MIDAS, All of Us) for population baseline. Private partner contributions (telehealth platforms, longevity clinics, EHR partners) for cash-pay outcomes. Medical society partnerships (A4M, Longevity Docs) for breadth.
03
Structural Invisibility
Cash-pay longevity patients generate no claims data. Competitors literally cannot see this population — and can't build what INEXION is building. The moat is in the data flow, not the data analysis.
04
The Comp Set
Flatiron Health — $1.9B Roche acquisition (oncology data). Verana Health — $287M+ raised (specialty registry). Komodo Health — $3.3B valuation. IQVIA — $3.5B+ analytics revenue. INEXION is the longevity equivalent.
How The Registry Is Built

Three data layers.
One unified schema.

INEXION integrates three data layers under a common data model: a public-data spine for population baseline, private partner contributions for the cash-pay longevity cohort, and medical society partnerships for breadth. Schema enforced at the integration layer. Scale without acquisition. Capital-light by design.

5
Public Datasets · Population Spine
NHANES, BRFSS, and HRS deployed today. MIDAS arriving within weeks. All of Us in pipeline. The population-level baseline against which partner-contributed cohorts are benchmarked.
50K+
Patient-Years · Series A Trigger
By 2027 across the partner network. 6+ partner integrations live (clinic, telehealth, EHR). First HEOR licensing contract signed. Series A raise begins.
100K+
Patient-Years · Scale
By 2028. 50+ partners across clinic, telehealth, and EHR networks. Multiple licensing contracts active. Registry publishable, licensable, foundation for clinical research partnerships.
Leadership

Operator-built. Clinically grounded. Ready to scale.

Ian Wendt
Ian Wendt
Founder & CEO
Ian brings three decades of biopharma commercial leadership to INEXION, with deep expertise in launch strategy, market access, and business development. Most recently Chief Commercial Officer at Jaguar Health, he founded INEXION to apply the same revenue discipline that launches blockbuster drugs to a new category: data-driven longevity clinic networks. Co-host of The RealPharma Podcast. MBA, Dalhousie University.
Na-Ri Oh
Na-Ri Oh, MD
Co-Founder & COO
Na-Ri is a physician and global biopharma executive whose career uniquely bridges clinical medicine and commercial strategy. MD from Heidelberg University as a Studienstiftung Scholar (awarded to fewer than 0.5% of German students). After practicing as an Infectious Disease physician, she held leadership roles at Boehringer Ingelheim and Gilead Sciences. Co-host of The RealPharma Podcast. Investor at Black Canyon Ventures and VC Fellow at the Material Change Institute.
Nirav Vira
Nirav Vira
Chief Technology Officer
25+ years building healthcare data platforms and AI-powered SaaS products. At Verana Health, built a data lake spanning 50 million patients and seven years of longitudinal EMR data. At WithMe Health as CTO, architected a multi-product ecosystem with three distinct revenue lines. At Change Healthcare, built the "Single Source of Truth" data infrastructure powering enterprise analytics. B.E., University of Mumbai.
Anant Vinjamoori
Anant Vinjamoori, MD
Chief Medical Officer
One of longevity medicine's most recognized physician-executives, combining rare clinical depth with commercial sophistication. MD from Harvard Medical School (President, MD/MBA Society) and MBA from Harvard Business School. Founder of Next Generation Medicine, previously at Virta Health and co-founder of Aavya Health. 11,400+ LinkedIn followers, international speaker, and 10+ peer-reviewed publications including work published by the Brookings Institution.
Research Lead
Research Lead
To Be Announced
INEXION's Research Lead drives the registry's clinical research roadmap, biomarker validation framework, and academic partnerships. Public announcement coming soon.
Carmela Breslin-Weaver
Carmela Breslin-Weaver
VP Operations
15+ years scaling non-clinical operating models across physician-led practices. Previously at Cardinal Health and Specialty Networks. MPH, University of Pittsburgh. MHA, University of Cincinnati.
For Physicians & Clinics
Join the registry.
Contribute your de-identified patient data. Access aggregated insights, benchmarking, and research collaboration in return. Standard Data Use Agreement only.
View Details
For Life Sciences
Get on the partner list.
The longevity data registry pharma can't build internally. Data licensing, clinical trial site network, and AI/ML training datasets — early-access partner program now live.
View Details
For Investors
Request the investor brief.
We're working with a select group of family offices and super angels in our $2M seed round.
Investor Overview